BACKGROUND: In the past 15 years mortality rates from liver disease have doubled in the UK. Brief alcohol advice is cost effective, but clinically meaningful reductions in alcohol consumption only occur in around 1 in 10 individuals. AIM: To provide evidence that detecting early liver disease in the community is feasible, practical, and that feedback of liver risk can increase the proportion of subjects reducing alcohol consumption. DESIGN AND SETTING: A community feasibility study in nine general practice sites in Hampshire. METHOD: Hazardous and harmful drinkers were identified by WHO AUDIT questionnaire and offered screening for liver fibrosis. RESULTS: In total, 4630 individuals responded, of whom 1128 (24%) hazardous or harmful drinkers were offered a liver fibrosis check using the Southampton Traffic Light (STL) test; 393 (38%) attended and test results were returned by post. The STL has a low threshold for liver fibrosis with 45 (11%) red, 157 (40%) amber, and 191 (49%) green results. Follow-up AUDIT data was obtained for 303/393 (77%) and 76/153 (50%) subjects with evidence of liver damage reduced drinking by at least one AUDIT category (harmful to hazardous, or hazardous to low risk) compared with 52/150 (35%, P<0.011) subjects without this evidence; in the subset of harmful drinkers patterns (AUDIT >15), 22/34 (65%) of STL positives, reduced drinking compared with 10/29 (35%, P<0.017) STL negatives. CONCLUSION: Detection of liver disease in the community is feasible, and feedback of liver risk may reduce harmful drinking.
BACKGROUND: In the past 15 years mortality rates from liver disease have doubled in the UK. Brief alcohol advice is cost effective, but clinically meaningful reductions in alcohol consumption only occur in around 1 in 10 individuals. AIM: To provide evidence that detecting early liver disease in the community is feasible, practical, and that feedback of liver risk can increase the proportion of subjects reducing alcohol consumption. DESIGN AND SETTING: A community feasibility study in nine general practice sites in Hampshire. METHOD: Hazardous and harmful drinkers were identified by WHO AUDIT questionnaire and offered screening for liver fibrosis. RESULTS: In total, 4630 individuals responded, of whom 1128 (24%) hazardous or harmful drinkers were offered a liver fibrosis check using the Southampton Traffic Light (STL) test; 393 (38%) attended and test results were returned by post. The STL has a low threshold for liver fibrosis with 45 (11%) red, 157 (40%) amber, and 191 (49%) green results. Follow-up AUDIT data was obtained for 303/393 (77%) and 76/153 (50%) subjects with evidence of liver damage reduced drinking by at least one AUDIT category (harmful to hazardous, or hazardous to low risk) compared with 52/150 (35%, P<0.011) subjects without this evidence; in the subset of harmful drinkers patterns (AUDIT >15), 22/34 (65%) of STL positives, reduced drinking compared with 10/29 (35%, P<0.017) STL negatives. CONCLUSION: Detection of liver disease in the community is feasible, and feedback of liver risk may reduce harmful drinking.
Authors: Emily C Williams; Daniel R Kivlahan; Richard Saitz; Joseph O Merrill; Carol E Achtmeyer; Kinsey A McCormick; Katharine A Bradley Journal: Ann Fam Med Date: 2006 May-Jun Impact factor: 5.166
Authors: Caroline Eyles; Michael Moore; Nicholas Sheron; Paul Roderick; Wendy O'Brien; Geraldine M Leydon Journal: Br J Gen Pract Date: 2013-08 Impact factor: 5.386
Authors: Caroline Eyles; Michael Moore; Nicholas Sheron; Paul Roderick; Wendy O'Brien; Geraldine M Leydon Journal: Br J Gen Pract Date: 2013-08 Impact factor: 5.386
Authors: Theresa Hydes; Michael Moore; Beth Stuart; Miranda Kim; Fangzhong Su; Colin Newell; David Cable; Alan Hales; Nick Sheron Journal: BMJ Open Date: 2021-02-11 Impact factor: 2.692
Authors: Penny A Cook; Michela Morleo; David Billington; Kevin Sanderson-Shortt; Colin Jones; Mark Gabbay; Nick Sheron; Mark A Bellis; Penelope A Phillips-Howard; Ian T Gilmore Journal: BMC Public Health Date: 2015-06-04 Impact factor: 3.295
Authors: A L Coughtrie; R N Whittaker; N Begum; R Anderson; A Tuck; S N Faust; J M Jefferies; H M Yuen; P J Roderick; M A Mullee; M V Moore; S C Clarke Journal: BMJ Open Date: 2014-10-30 Impact factor: 2.692